A Primary Lung and Breast Cancer Patient with Germline EGFR R776H Mutation: A Case Report and Literature Review

For advanced non-small cell lung cancer (NSCLC) patients with common epidermal growth factor receptor (EGFR) mutations (exon 19 deletions or the exon 21 L858R mutation), tyrosine kinase inhibitors (TKIs) are the standard therapies. However, EGFR germline mutations are extremely rare in lung cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Dan, Liu, Xin, Cui, SaiQiong, Yang, DaFu, Zhu, Yue, Pan, Evenki, Yang, Peng, Dai, ZhaoXia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868143/
https://www.ncbi.nlm.nih.gov/pubmed/36698436
http://dx.doi.org/10.2147/OTT.S391766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9868143/
https://www.ncbi.nlm.nih.gov/pubmed/36698436
http://dx.doi.org/10.2147/OTT.S391766

Ejemplares similares